CORT
Corcept Therapeutics Inc (CORT) rating initates by Wolfe Research
Corcept Therapeutics Inc’s recently made public that its Chief Development Officer Guyer William unloaded Company’s shares for reported $1.6 million ...
Corcept Therapeutics Inc [CORT] Investment Appeal on the Rise
Corcept Therapeutics Inc’s filing revealed that its Officer Guyer William acquired Company’s shares for reported $1.6 million on Dec 02 ...
Corcept Therapeutics Inc [CORT] Chief Development Officer makes an insider purchase of 4,500 shares worth 0.36 million.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Negative sentiment towards CORT reflected in surge in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corcept Therapeutics ...
Corcept Therapeutics Inc [CORT] stock for 1,507,122 USD was sold by Guyer William
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corcept Therapeutics ...
Analyzing Corcept Therapeutics Inc (CORT) After Recent Trading Activity
Corcept Therapeutics Inc’s filing revealed that its Officer BELANOFF JOSEPH K acquired Company’s shares for reported $2.94 million on Nov ...
Days-to-cover ratio for CORT declines to 9.72 due to decline in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corcept Therapeutics ...
